Skip to main content
. 2019 Sep 3;11(9):2069. doi: 10.3390/nu11092069

Table 1.

Anthropometric and metabolic effects in patients with obesity and type 2 diabetes (T2D) before and after Roux-en-Y gastric bypass (RYGB).

Characteristics Before Surgery After Surgery
n (males, females) 25 (11, 14) 25 (11, 14)
Age (years) 50 ± 2 51 ± 2
BMI (kg/m2) 44.2 ± 1.3 33.6 ± 1.6 ***
Body fat (%) 49.9 ± 1.5 39.6 ± 2.0 ***
Waist (cm) 128 ± 3 107 ± 3 ***
Waist-to-hip ratio 1.00 ± 0.01 0.97 ± 0.02 **
SBP (mmHg) 128 ± 3 120 ± 3 **
DBP (mmHg) 80 ± 2 73 ± 1 ***
Fasting glucose (mg/dL) 133 ± 7 115 ± 9
Fasting insulin (μU/mL) 21.3 ± 2.5 8.0 ± 1.2 ***
HOMA 6.6 ± 0.8 2.1 ± 0.3 ***
QUICKI 0.302 ± 0.006 0.363 ± 0.010 ***
HbA1c (%) 7.2 ± 0.2 6.4 ± 0.2 **
Triglycerides (mg/dL) 140 ± 10 97 ± 11 **
Total cholesterol (mg/dL) 185 ± 7 159 ± 7 *
LDL-cholesterol (mg/dL) 111 ± 6 90 ± 5 *
HDL-cholesterol (mg/dL) 46 ± 2 51 ± 2 *
Leptin (ng/mL) 45.3 ± 5.6 15.1 ± 2.4 ***
Adiponectin (µg/mL) 6.73 ± 0.67 11.68 ± 0.81 ***
Adpn/Lep ratio 0.21 ± 0.03 1.20 ± 0.19 ***
Uric acid (mg/dL) 5.8 ± 0.3 4.5 ± 0.2 ***
Creatinine (mg/dL) 0.80 ± 0.04 0.77 ± 0.03 *
CRP (mg/L) 8.5 ± 1.6 2.1 ± 1.0 *
Fibrinogen (mg/dL) 385 ± 21 348 ± 23
von Willebrand factor (%) 152 ± 11 138 ± 14
Homocysteine (μmol/L) 10.2 ± 1.2 9.3 ± 1.1
AST (IU/L) 15 ± 1 18 ± 2
ALT (IU/L) 21 ± 2 27 ± 5
AST/ALT 0.78 ± 0.07 0.87± 0.07
γ-GT (IU/L) 35 ± 6 16 ± 2 **

Adpn/Lep, adiponectin/leptin ratio; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CRP, C-reactive protein; DBP, diastolic blood pressure; γ-GT, γ-glutamyltransferase; HbA1c, glycated hemoglobin; HOMA, homeostasis model assessment; NG, normoglycemic; QUICKI, quantitative insulin sensitivity check index; SBP, systolic blood pressure; T2D, type 2 diabetes. Data are mean ± SEM. Differences between groups were analyzed by two-paired Student t tests. * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. before surgery.